bioLytical Laboratories Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • bioLytical Laboratories's estimated annual revenue is currently $30.9M per year.(i)
  • bioLytical Laboratories's estimated revenue per employee is $251,000

Employee Data

  • bioLytical Laboratories has 123 Employees.(i)
  • bioLytical Laboratories grew their employee count by 2% last year.

bioLytical Laboratories's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
VP Quality & RegulatoryReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Director, Information TechnologyReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Engineering ManagerReveal Email/Phone
9
Product Launch & Sustaining ManagerReveal Email/Phone
10
Supply Chain ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is bioLytical Laboratories?

Biolytical Laboratories Inc. based in Richmond, BC, Canada is a privately-owned Canadian Company federally incorporated in 2002. Our mission is to improve the quality of people's lives by providing innovative solutions for infectious disease diagnosis, the first step in the linkage of patients to appropriate care and treatment. Today, the company sells and markets its INSTI HIV test supported by worldwide regulatory approvals including US FDA approval, Health Canada approval and CE mark in Europe. Our product provides a highly accurate HIV test result in as little as 60 seconds which translates into a compelling value proposition for patients, healthcare professionals, payers and public health organizations. We have an active R&D program and our pipeline includes INSTI tests for diseases such as Hepatitis C and Syphilis. The company also provides contract services to adapt the INSTI platform to meet custom functional and technical diagnostic testing requirements. Our vision is to be a global leader in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostic devices.

keywords:N/A

N/A

Total Funding

123

Number of Employees

$30.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

bioLytical Laboratories News

2022-04-17 - HIV Self Test Kits Market Size, Scope And Outlook | OraSure ...

... United Kingdom Ltd., ECO Diagnostica, bioLytical Laboratories, Sedia Biosciences Corporation, Orangelife Com rcio e Ind stria LTDA and WAMA Diagnostica.

2022-03-30 - Health Canada authorises bioLytical's Covid-19 antigen test

Credit: bioLytical Laboratories. Health Canada has granted authorisation to medical diagnostics firm bioLytical Laboratories' iStatis COVID-19...

2022-03-22 - bioLytical Laboratories Inc. Receives Health Canada ...

bioLytical Laboratories Inc. is a privately-owned Canadian company focused on the research, development, and commercialization of rapid in-vitro...

2019-09-08 - Bioanalytical Services Market Set For Massive Growth In In ...

The U.S. FDA guidance in 2001 defined bioanalytical services as ... Inc., Charles River Laboratories International, Inc., Bio-Rad Laboratories, ...

2019-09-07 - bioLytical Laboratories Earns MDSAP Certification, Highest ...

RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in the development and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M123-6%$19.1M
#2
$17.8M1238%N/A
#3
$31.2M123-4%N/A
#4
$30.1M12310%N/A
#5
$17.8M12322%N/A